We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a ...

DexCom's stock is up more than 560% in the past 10 years. 2024, however, has been a different story. The healthcare stock is in a tailspin, trading down more than 50% from its high after a steep ...

DexCom's stock fell sharply after mixed Q2 earnings and lowering full-year guidance, signaling a revaluation phase with lower ...

Dexcom announced today that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.

Dexcom shares fell on Thursday after the company released third-quarter results that showed slow revenue growth ...

DexCom reported quarterly earnings of 45 cents per share, which beat the analyst consensus estimate of 43 cents. Quarterly revenue came in at $994.2 million which beat the analyst consensus estimate ...

DexCom (NASDAQ:DXCM – Free Report) had its price objective boosted by Wells Fargo & Company from $80.00 to $90.00 in a ...

DexCom's stock crashed after the company lowered ... The healthcare stock is in a tailspin, trading down more than 50% from its high after a steep sell-off following its latest earnings report.